Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124529533 | 12452953 | 3 | F | 20160630 | 20160609 | 20160727 | PER | US-PFIZER INC-2016263987 | PFIZER | 75.00 | YR | F | Y | 80.74000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124529533 | 12452953 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | 600 MG, 4X/DAY | U | M86800 | 20235 | 600 | MG | QID | ||||||
| 124529533 | 12452953 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | U | 20235 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124529533 | 12452953 | 1 | Neuropathy peripheral |
| 124529533 | 12452953 | 2 | Herpes zoster |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124529533 | 12452953 | Drug ineffective | |
| 124529533 | 12452953 | Product quality issue | |
| 124529533 | 12452953 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |